Feldan Therapeutics

About:

Feldan Therapeutics has developed a patented peptide-based technology platform.

Website: http://www.feldan.com/

Top Investors: Fonds de solidarité FTQ, National Institutes of Health, Investissement Quebec, AQC Capital, Amgen Ventures

Description:

Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of the unique characteristics of the Shuttle.